Feed BNGO
BN

Bionano Genomics, Inc.

BNGO · NASDAQ

$1.73 -1.14% (-$0.02)
1M +41.80%
Market Cap $19.9M
P/E Ratio -
Div. Yield -
ROE 78.78%
Piotroski F-Score Moderate
4/9
Valuation
100 /100
Cheap
P/B 0.63x
P/S 0.66x
P/FFO N/A
Growth
19 /100
Declining
Book val. growth 43.73%
Rev. growth 0.84%
FCF growth N/A
Profitability
19 /100
Weak
Op. margin 106.67%
Gross margin 47.50%
FCF margin 67.87%
Quality
8 /100
Poor
ROA 67.58%
ROIC 83.94%
Asset turnover 0.63x
Debt
69 /100
Low
Int. coverage -149.69x
Debt/Equity 0.21x
Current ratio 2.48x
Stability
20 /100
Unstable
EPS volatility 80.71%
Beta 1.65x
Profitable years 0

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre BNGO
Online

Despre companie

Bionano Genomics (BNGO) is a biotechnology company focused on developing and commercializing its advanced genomic platform. This platform enables the study of the structure and variations of the human genome with high accuracy and detail. Bionano Genomics aims to provide tools for genetic research, genetic disease diagnostics, and personalized medicine. Bionano Genomics stock is suitable for investors interested in the biotechnology sector and innovative technologies in the field of genetics. Add Bionano Genomics stock to your watchlist on Bulios and stay informed about the latest advancements in genomics and biotechnology.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Albert A. Luderer

Employees

96

Headquarters

San Diego

Evenimente viitoare

12 NOV.

Earnings

Upcoming earnings report

52d

Folosim cookie-uri esențiale pentru funcționarea site-ului și cookie-uri analitice opționale pentru a măsura utilizarea. Consultați Politica de confidențialitate.